Latest News & Features
Biotechnology
The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert. 24 September 2024
Americas
Biotech’s motion for preliminary injunction to prevent Eylea biosimilar rejected I Regeneron has filed multiple suits over rivals’ copies of aflibercept. 24 September 2024
Unified Patent Court
The president of the appeals court reveals his thinking on transparency, bringing more countries on board, and the hidden delays in the EU Commission’s SEP plan. 24 September 2024
Americas
New York court grants Gilead’s contempt motion | Defendant violated asset freeze order by selling and mortgaging properties 19 September 2024
Careers
Prior to his new role, the senior hire spent eight years as an in-house counsel at a major pharma company. 19 September 2024
Unified Patent Court
The founding partner of Bird & Bird’s Dutch office explores his recent victory for Edwards Lifesciences and his active role at the court. 19 September 2024
Americas
Court finds United Therapeutics breached settlement agreement by restricting distribution of cartridges | Sandoz alleged rival hampered launch of generic medication for pulmonary arterial hypertension 17 September 2024
Unified Patent Court
The court rejected the medical device company’s auxiliary requests and nixed patent in 17 territories although it seems receptive to these amendments in general, say Laura Orlando and Rachel Montagnon of Herbert Smith Freehills. 17 September 2024
Biotechnology
Sanofi will be responsible for global commercialisation of the medicine, used to treat neuroendocrine tumours | Pharma giant will pay up to $320m plus royalties to two biotech companies. 13 September 2024
Unified Patent Court
Data visualisations based on the court’s activity from June to August reveal that the use of English is growing, German divisions are dominating, and appeals are creeping up, writes Marisa Woutersen. 12 September 2024